Dulaglutide vs Pemvidutide

Dulaglutide (brand name Trulicity) is an FDA-approved GLP-1 receptor agonist used to treat type 2 diabetes and reduce cardiovascular risk; it is taken as a weekly injection. Pemvidutide, still in development, is a dual GLP-1 and glucagon receptor agonist that has not yet been approved for any conditions.

AI summary of the sources below.